182 related articles for article (PubMed ID: 26405806)
21. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
22. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
23. Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia.
Yu R; Yang Y; Cui Z; Zheng L; Zeng Z; Zhang H
Peptides; 2014 Oct; 60():41-50. PubMed ID: 25086267
[TBL] [Abstract][Full Text] [Related]
24. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides.
Shen D; Liang K; Ye Y; Tetteh E; Achilefu S
FEBS Lett; 2007 May; 581(9):1793-9. PubMed ID: 17416362
[TBL] [Abstract][Full Text] [Related]
25. Arginine modification of lycosin-I to improve inhibitory activity against cancer cells.
Zhang P; Ma J; Yan Y; Chen B; Liu B; Jian C; Zhu B; Liang S; Zeng Y; Liu Z
Org Biomol Chem; 2017 Nov; 15(44):9379-9388. PubMed ID: 29090725
[TBL] [Abstract][Full Text] [Related]
26. Effective antibacterial action of tat (47-58) by increased uptake into bacterial cells in the presence of trypsin.
Jung HJ; Jeong KS; Lee DG
J Microbiol Biotechnol; 2008 May; 18(5):990-6. PubMed ID: 18633303
[TBL] [Abstract][Full Text] [Related]
27. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
28. Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.
Liu R; Xi L; Luo D; Ma X; Yang W; Xi Y; Wang H; Qian M; Fan L; Xia X; Li K; Wang D; Zhou J; Meng L; Wang S; Ma D
J Control Release; 2012 Aug; 161(3):893-902. PubMed ID: 22580115
[TBL] [Abstract][Full Text] [Related]
29. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G
Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.
Zhang P; Lock LL; Cheetham AG; Cui H
Mol Pharm; 2014 Mar; 11(3):964-73. PubMed ID: 24437690
[TBL] [Abstract][Full Text] [Related]
31. Tat peptide mediated cellular uptake of SiO2 submicron particles.
Mao Z; Wan L; Hu L; Ma L; Gao C
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):432-40. PubMed ID: 19846283
[TBL] [Abstract][Full Text] [Related]
32. A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.
Brabant M; Baux L; Casimir R; Briand JP; Chaloin O; Porceddu M; Buron N; Chauvier D; Lassalle M; Lecoeur H; Langonné A; Dupont S; Déas O; Brenner C; Rebouillat D; Muller S; Borgne-Sanchez A; Jacotot E
Apoptosis; 2009 Oct; 14(10):1190-203. PubMed ID: 19693674
[TBL] [Abstract][Full Text] [Related]
33. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.
Heulot M; Chevalier N; Puyal J; Margue C; Michel S; Kreis S; Kulms D; Barras D; Nahimana A; Widmann C
Oncotarget; 2016 Sep; 7(39):64342-64359. PubMed ID: 27602963
[TBL] [Abstract][Full Text] [Related]
34. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
35. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
36. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.
Sacco E; Metalli D; Spinelli M; Manzoni R; Samalikova M; Grandori R; Morrione A; Traversa S; Alberghina L; Vanoni M
Biotechnol Adv; 2012; 30(1):233-43. PubMed ID: 21620943
[TBL] [Abstract][Full Text] [Related]
37. Computational study, synthesis and evaluation of active peptides derived from Parasporin-2 and spike protein from Alphacoronavirus against colorectal cancer cells.
Cruz J; Suárez-Barrera MO; Rondón-Villarreal P; Olarte-Diaz A; Guzmán F; Visser L; Rueda-Forero NJ
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34796903
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate).
Wang C; Qiao L; Zhang Q; Yan H; Liu K
Int J Pharm; 2012 Jul; 430(1-2):372-80. PubMed ID: 22531849
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.
Ekokoski E; Aitio O; Törnquist K; Yli-Kauhaluoma J; Tuominen RK
Eur J Pharm Sci; 2010 Aug; 40(5):404-11. PubMed ID: 20433920
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
